Molnupiravir and Nirmatrelvir/Ritonavir: The New Available Antiviral Options for COVID-19
Coronavirus disease 2019 (COVID-19) is a respiratory tract disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). With the complexity of multimorbidity in Indonesia, it is crucial to find another line of antiviral for COVID-19. This article aims to review two antivirals, mol...
Shranjeno v:
| Principais autores: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Interna Publishing
2022-12-01
|
| Serija: | Acta Medica Indonesiana |
| Teme: | |
| Online dostop: | https://actamedindones.org/index.php/ijim/article/view/2115 |
| Oznake: |
Brez oznak, prvi označite!
|